Valbiotis SA (FR:ALVAL) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Valbiotis SA is set to launch its innovative dietary supplement, Valbiotis®PRO Metabolic Health, in France by early 2025. This plant-based product targets metabolic disorders like dysglycemia and type 2 diabetes, with its effectiveness backed by extensive clinical testing. The company aims to leverage the successful strategy of its previous product, Valbiotis®PRO Cholesterol, for this launch.
For further insights into FR:ALVAL stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue